We manufacture a large range of pharmaceutical formulations covering a board spectrum of therapies. It includes generics, branded generics, specialty, complex or difficult to make technology-intensive products, over-the-counter (OTC), antiretroviral (ARVs), Active Pharmaceutical Ingredients (APIs). Our broad portfolio of more than 300 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, inhalers etc.
Our core strength lies in our ability to develop generics and technologically complex products in formulations, process chemistry and analytical development.
Our capabilities extend beyond the development of differentiated products, including liposomal products, inhalers, lyophilized injections, and sustained release dosage forms, pellets etc.
